| Main Subject |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Management > Workflow Technology |
|
Main Subject - Workflow Technology
Workflow technology made its presence first in the 1980's. It was first incorporated in the insurance industry According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product , where it drastically brought down the documentation involved. It was also used for imaging in case of variou ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in s business processes. Since then, there have been several industries that have incorporated its services. Heal lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. thcare has also recently joined the other industries in incorporating the benefits of workflow technology in c here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe reating a more effective work environment. Workflow typically deals with the responsibilities, assets, and tr d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro ggers related with a definite procedure. Workflow technology deals with the computerization of these processes ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc . They are able to synchronize and supervise the various actions related with distinct procedures. It is able easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi to implement the various related business rules by the presence of a workflow engine. Certain procedures do n nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically ot adapt very well to automation. Processes that involve sequential or parallel steps, in their implementation and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ are able to suit rapidly to such computerization. These processes are also found to require automation at spe ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi ific points, communicating the tasks as well as alerting mechanisms. Task communication, if not carried out pr ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a operly, leads to serious mistakes and expensive delays. The common features of automating any process involve dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod user adoption. For this, specific systems need to be integrated into the existing workflow. It is imperative cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin that the systems have the ability to coordinate a multidisciplinary association of processes. It is also neces tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen sary for the system to have decision maintaining abilities. Thus, installation of such a workflow system is no t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel simply the incorporation of software but should be a means of automating and if necessary bring alterations t ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust o the process.
There are several benefits of workflow automation such as cost cutback, enhanced operational e y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products fficacies, reduction of mistakes, superior communication, and audit of the procedures. Automation should aim f . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de or and bring about improvement. Hence, it is also important to make the related manual processes effective to elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip enhance its effect when automated. It should also be aimed at streamlining and enhancing the current procedure tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:5 Reasons Why You Should Establish an Offshore Company Data Mining Models - Tom's Ten Data Tips
|